| Low abundance of circulating tumor DNA in localized prostate cancer ST Hennigan, SY Trostel, NT Terrigino, OS Voznesensky, RJ Schaefer, ... JCO precision oncology 3, 1-13, 2019 | 93 | 2019 |
| MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity NC Whitlock, SY Trostel, S Wilkinson, NT Terrigino, ST Hennigan, R Lake, ... Oncogene 39 (34), 5663-5674, 2020 | 19 | 2020 |
| Optimized red-absorbing dyes for imaging and sensing JB Grimm, AN Tkachuk, R Patel, ST Hennigan, A Gutu, P Dong, V Gandin, ... Journal of the American Chemical Society 145 (42), 23000-23013, 2023 | 12 | 2023 |
| Tracing the clonal dynamic of metastatic castration-resistant prostate cancer over immunotherapy using circulating tumor DNA C Li, A Baj, CCY Seo, NT Terrigino, JR Bright, ST Hennigan, IM King, ... CANCER RESEARCH 84 (3), 2024 | | 2024 |
| Abstract PR005: Tracing the clonal dynamic of metastatic castration-resistant prostate cancer over immunotherapy using circulating tumor DNA C Li, A Baj, CCY Seo, NT Terrigino, JR Bright, ST Hennigan, IM King, ... Cancer Research 84 (3_Supplement_2), PR005-PR005, 2024 | | 2024 |
| Optimized Red-Absorbing Dyes for Imaging and Sensing LDL Jonathan B Grimm, Ariana N Tkachuk, Ronak Patel, S Thomas Hennigan ... Journal of the American Chemical Society 145 (42), 23000-23013, 2023 | | 2023 |
| Abstract A053: Epigenomic analyses of circulating tumor DNA in patients with metastatic castration resistant prostate cancer (mCRPC) treated with immune checkpoint blockade and … A Baj, CCY Seo, NT Terrigino, JR Bright, ST Hennigan, IM King, ... Cancer Research 83 (11_Supplement), A053-A053, 2023 | | 2023 |
| Multiple primary prostate tumors with differential drug sensitivity. SC Wilkinson, H Ye, N Terrigino, N Carrabba, R Atway, SY Trostel, ... Journal of Clinical Oncology 38 (6_suppl), 342-342, 2020 | | 2020 |
| Development of an allele-specific assay for detecting circulating tumor DNA in prostate cancer NT Terrigino, ST Hennigan, S Trostel, SC Wilkinson, H Ye, AG Sowalsky Cancer Research 79 (13_Supplement), 736-736, 2019 | | 2019 |
| Genetic features predictive of response to anti-androgen therapies in aggressive prostate cancer S Wilkinson, AG Sowalsky, H Ye, N Carrabba, R Atway, SY Trostel, ... MOLECULAR BIOLOGY OF THE CELL 29 (26), 248-249, 2018 | | 2018 |
| Genomic correlates of imaging response in men receiving intense neoadjuvant androgen-deprivation therapy S Wilkinson, H Ye, R Atway, SY Trostel, NC Whitlock, ST Hennigan, ... CANCER RESEARCH 78 (16), 101-101, 2018 | | 2018 |
| Molecular and histopathologic correlates of imaging and biological responses to neoadjuvant GnRH agonist plus enzalutamide for high risk prostate cancer. AG Sowalsky, S Wilkinson, H Ye, DJ VanderWeele, B Turkbey, ... Journal of Clinical Oncology 36 (6_suppl), 34-34, 2018 | | 2018 |
| Abstract LB-275: Precise enumeration of cell-free DNA from patient-derived cell lines S Hennigan, S Trostel, AG Sowalsky Cancer Research 77 (13_Supplement), LB-275-LB-275, 2017 | | 2017 |
